Drug-Induced Liver Disease
Drug-Induced Liver Disease
Explore linked clinical trials. Standard reference: MESH:M0006174657 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Drug-induced Liver Injury: Itching Study | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, drug-induced liver injury, liver disorder, poisoning, skin disorder | Recruiting | Not stated | 2026-07-27 | NCT06446609 | |
| Drug-Induced Liver Injury (DILI) Network Retrospective | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2026-04-08 | NCT00360646 | |
| Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, drug-induced liver injury, hyperbilirubinemia, liver disorder, liver failure, poisoning | Recruiting | Not applicable | 2025-12-18 | NCT06922669 | |
| Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Infections, bacterial infectious disease, drug-induced liver injury, gram-positive bacterial infections, liver disorder, mycobacterial infectious disease, poisoning, tuberculosis | Not yet recruiting | Phase 1 | 2025-07-10 | NCT07058090 | |
| A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Active, not recruiting | Not stated | 2025-05-04 | NCT06670391 | |
| Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Not yet recruiting | Phase 2 / Phase 3 | 2025-01-28 | NCT06797011 | |
| Prospective Comparative Validation Study of RUCAM and RECAM | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, drug-induced liver injury, liver disorder, poisoning | Recruiting | Not stated | 2025-01-13 | NCT06771011 |